According to AN2 Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.67. In 2022 the company made an earnings per share (EPS) of -$7.83 a decrease over its 2021 EPS that were of -$3.07.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$4.20 | -46.37% |
2022 | -$7.83 | 154.79% |
2021 | -$3.07 |